Objective: Heterotopic ossi®cations (HO) occur in about 20% of patients with spinal cord injury and may seriously compromise the rehabilitation process. The aim of the present study was to ascertain whether radiotherapy (RT) administered early in the course of the disease prevents the manifestation of HO and whether in patients, whose HO have been resected, recurrence can be avoided. Methods: Thirty-six patients (46 joints) were irradiated; 33 patients were evaluable. Mean follow up was 23.6 months. In 27 patients RT was performed as primary treatment in the in¯ammatory phase of soft tissue swelling that precedes manifest HO. Eleven patients were treated after resection of manifest HO, while two had primary and postoperative RT in dierent joints. The dose was 10 Gy in fractions of 2 ± 2.5 Gy in 25 patients. Four patients were treated with total doses between 7.5 and 20 Gy. Seven patients received single dose irradiation with 8 Gy. RT was performed with 8 MV photons after simulation on the basis of CT scans. Results: The mean duration of follow up was 23.6 months. Thirty of the 36 irradiated patients showed no progression of HO. In three patients reossi®cations after therapy caused a moderate decrease in joint mobility. No relevant adverse eects were observed. Conclusion: These results suggest that RT is a safe and eective local treatment option for spinal cord injury patients with HO. Spinal Cord (2000) 38, 33 ± 36
Introduction
Since the beginning of the century, when Dejerine et al 1 reported on`paraosteoarthropathies' in patients with spinal cord injuries (SCI), heterotopic ossi®cation (HO) in these patients has been known as a clinically relevant problem occurring in about 20% of these patients. 2 ± 5 As HO in spinal cord injury patients may decrease the range of motion of the aected joints and thus seriously compromise rehabilitation, 6 it seems desirable to ®nd ways of either preventing or stabilising this pathological process at an early stage. Hitherto, no local therapeutic options have been established for HO except extensive resection. Surgery, however, should not be performed earlier than 1 ± 1.5 years after onset of the HO. 4 As radiotherapy (RT) is well known to prevent HO when administered after total hip arthroplasty, it may be hypothesised to be an appropriate treatment option for SCI patients with HO as well. The purpose of the present paper is to evaluate the ecacy of RT to stop progression of manifest or incipient heterotopic bone formation or to prevent reossi®cation after surgical treatment.
Patients and methods
The total number of SCI patients included in the study was 36 (four females, 32 males); the mean age was 33.6 years (17 ± 59 years). Forty-six joints were irradiated (43 hips, one shoulder, one elbow, one knee). Thirtythree patients were evaluable; three were lost to followup. The mean duration of follow up was 23.6 months (4 ± 98 months).
Diagnosis was based on clinical examination, X-ray studies (n=10) and computed tomography (CT) (n=23). Reevaluation in the follow up included clinical examination analysing the range of motion of the aected joint and radiography in order to assess ossi®cations around the hip according to the Brooker score 7 or in more distal soft tissues and muscles. In 27 patients (33 joints) RT was a primary treatment in the status of myositis. These patients had shown the respective clinical signs such as soft tissue swelling, hyperthermia and erythema. CT was then performed to visualize the aected region and con®rm the clinical diagnosis. RT was started as soon as possible, when ossi®cations were minimal or even not yet visible at all. These patients were judged as having`incipient' HO. In CT the in¯ammatory process was visualized as hypodensity and soft tissue swelling. Additionally, small spots of ossi®cations were sometimes present. Eleven patients (13 joints) had manifest ossi®cations which had to be resected. Postoperative RT was performed 24 ± 36 h after surgery. Two of the 36 patients had primary and postoperative RT in dierent joints.
The majority of patients (25/36) received 10 Gy in fractions of 2 ± 2.5 Gy. Only three patients were treated with higher doses: the ®rst patient of all received 20 Gy, one patient was treated with 15 Gy and one with 12 Gy. One patient received only 7.5 Gy due to acute fever. In the second period of the study the treatment regimen was changed and the seven patients treated since 12/96 received single dose irradiation with 8 Gy.
Radiotherapy was performed with a linear accelerator using 8 MV photons. The treatment volume enclosed the aected region with a small safety margin. Field shape was based mainly on the findings of CT depicted as soft tissue swelling. Critical organs ± especially the gonads in young patients when the hips were irradiated ± were spared as far as possible by using individual blocks or special gonadal shielding. Gonadal dose was measured using a special dosimeter (Diamond Detector, PTW).
Results

Treatment ecacy
Thirty of the 33 evaluable patients showed neither progression of incipient HO nor recurrence of resected bone formations. In all these patients mobilisation and rehabilitation could be carried out as desired.
Analysing the treated joints, 16 of the 32 primarily irradiated hips did not show any radiographic abnormalities in the follow up. According to the grading proposed by Brooker 7 two hips were scored as grade 1, six hip joints as grade 2 and eight as grade 3 (Table 1) . Thus, three hips showed progression after RT.
In the postoperative group 11 hip joints were irradiated after resection of manifest HO. The two hips without radiographic abnormalities after resection remained free of any morphologic alterations in the follow up. Prior to RT four hips showed Brooker grade 1, ®ve hips had grade 2 alterations. In the follow up three hips had Brooker grade 1, ®ve hips grade 2 and one hip grade 3 ossi®cations (Table 2) . Abnormalities according to Brooker grade 4 did not occur.
Radiograms of the other three irradiated joints (one knee, one elbow, one shoulder) were assessed according to the classi®cation proposed by Garland. 8 Mild radiographic abnormalities occurred in the knee, moderate alterations in the elbow and shoulder. All these ®ndings remained unchanged after RT.
Adverse eects
No relevant adverse eects occurred. One patient treated postoperatively developed fever the day after radiotherapy probably not related to RT. Delayed wound healing in operated patients was not observed.
Gonadal doses
When the hip was irradiated, the mean gonadal dose was measured as 1.2 ± 1.5 cGy per Gy of total dose using gonadal shielding.
Discussion
As HO occurs in up to 20% of patients with spinal cord injuries and then may pose serious problems for rehabilitation, it seems desirable to establish methods for early diagnosis and treatment in order to prevent progression. HO is preceded by an acute in¯ammatory process aecting soft tissues and muscles in the neighbourhood of joints. In most cases the onset of the disease occurs between 4 weeks and 3 months (at the latest 6 months) after the initial trauma. 2, 9 Sometimes there is a coincidence with the phase of mobilisation and passive movements of the joints. 10 Radiotherapy has not been established as a treatment for HO in patients with spinal cord injuries. A clinical rationale for irradiation as an appropriate treatment for HO in SCI patients may be derived from the fact that RT is an established means of preventing HO after hip replacement and has been performed since the early 1970s. The ®rst trials started using 20 Gy, but doses were then reduced to 10 Gy, 11, 12 which was regarded as standard treatment Moreover, it is well known that low-dose RT has an excellent antiphlogistic eect, which could particularly be expected in the in¯ammatory process aecting the soft tissues preceding the development of HO.
With regard to the clinical ecacy of this treatment modality in the prevention of heterotopic bone formation, RT seems to suggest itself for application in SCI patients as well. However, to our knowledge, no systemic investigations on the use of external RT for SCI patients have been published. Some publications exist describing postoperative RT after resection of HO. In a recent study of the results of resection of HO in SCI patients, postoperative irradiation was used, and the excellent outcome of this combined modality treatment was attributed partly to radiotherapy. 16 However, doses and technique of RT were not described in detail and no information about indication for RT or patient selection was given. Another clinical study reports excellent results in eight patients (®ve of which had SCI) whose HO of the elbow was resected and irradiated postoperatively. No recurrences occurred. 17 Stover et al 4 performed postoperative RT in two out of 21 patients but found the eects dicult to determine as other treatment modalities were also employed.
In another publication, which is based on two cases, pain relief and an increased range of motion was observed after RT in patients with established ossi®cations. 18 Our group reported preliminary results in 1995, 19 suggesting the ecacy of RT not only when performed postoperatively but particularly as a primary treatment in the early stage of the disease, ie in the in¯ammatory phase preceding the manifest ossi®cations. However, in this study the follow up time was too short to permit de®nitive conclusions.
Corresponding to the results of our preliminary study, 19 the present ®ndings con®rmed the ecacy of RT as a primary treatment for incipient HO; RT was equally eective in the postoperative situation. In contrast to our ®rst results the mean follow up time of 23.6 months now permits a more pertinent conclusion. Further progression is unlikely, as the highest frequency of occurrence is at 1 ± 4 months after the spinal lesion. 2, 20 Only three out of 33 (510%) patients developed moderate progression of their ossi®cations after RT. These patients were not treated at the optimal time point, ie the very beginning of the disease but after manifest onset of HO.
There was no dierence of ecacy in the fractionated regimen compared to the single dose treatment. In the ®rst treatment period patients were irradiated with fractionated RT according to the`gold standards' in prophylactic RT for prevention of HO in total hip arthroplasty. When some randomized trials.
14,15 had shown no dierence in outcome between the two schedules in hip replacement patients, one single fraction with 8 Gy was used since 1996. With regard to organisational feasibility single dose treatment is favourable as specialized rehabilitation centres eventually are not equipped with a radiotherapy department and the transportation is arduous for the patients.
These results seem to compare favourably to the treatment with systemic diphosphonate treatment. Especially in older investigations the ecacy of etidronate seemed uncertain. 8, 21 Banovac described prevention of HO in 79% in patients with positive bone scan and negative radiogram and only in six of 13 patients HO could be prevented when patients had radiographically visible HO. 22 However, treatment ecacy with etidronate seems to be higher when used in a very early stage of the disease. 23 Moreover, RT, especially when performed as single dose treatment, is extremely cost eective compared to several months of medical treatment.
No relevant adverse eects have yet been observed in our patients. However, the potential long-term risk of a radiogenic tumor induction for patients of predominantly young age has to be taken into consideration. There seems to be no relevant risk of a local tumor induction within the radiation ®eld (ie sarcoma) as this is not supposed to occur after doses smaller than 30 Gy. 24 The potential actuarial risk of systemic tumor induction (years or decades after treatment) is dicult to quantify as data are derived from a single whole-body exposition especially at Hiroshima and Nagasaki, 25, 26 whereas in the therapeutic situation only a small part of the body is exposed to relevant doses. These small risks must be weighed carefully against the risk of hampered rehabilitation with serious impairment of life quality, particularly in the absence of other treatment options with proven ecacy.
As patients with SCI are often young males, some of whom will wish to father children, special care has to be taken to preserve fertility. This is especially important in view of the fact that modern fertilization techniques permit reproduction even in patients with a loss of potency. We therefore used careful gonadal shielding with a special lead capsule. The measured gonadal dose was only 10% to 15% of the dose (1Gy) considered critical for infertility. 27 
Conclusion
The results of the present study con®rm that RT for the treatment of HO in patients with SCI is eective as a primary therapy as well as postoperatively. When used as a primary treatment RT should be performed as early as possible after the onset of the disease. A prospective study evaluating the ecacy of single dose radiotherapy is currently under way.
